Treatment outcome of tuberculosis patients detected using accelerated vs. passive case finding in Myanmar

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1145-1151. doi: 10.5588/ijtld.18.0038.

Abstract

Setting: Several projects involving accelerated or active case finding (ACF) of tuberculosis (TB) cases are being implemented in Myanmar. However, there is a concern that patients detected using ACF have poorer TB treatment outcomes than those detected using passive case finding (PCF).

Objective: To assess differences in the demographics, clinical profile and treatment outcomes of patients detected using ACF and PCF.

Design: Retrospective cohort study of TB patients diagnosed and enrolled for treatment during 2014-2016.

Results: Of 16 048 patients enrolled, 2226 (16%) were detected using ACF; the treatment success rate (cured and completed) was 88%. A higher proportion of cases detected using ACF were aged 55 years, human immunodeficiency virus (HIV) negative and sputum smear-positive pulmonary TB. After adjusting for differences in demographic and clinical characteristics, we found that treatment outcomes in patients detected using ACF and PCF were not significantly different (adjusted relative risk [aRR] 0.89, 95%CI 0.78-1.00). Male sex, age  55 years, patients with a previous history of TB and HIV positivity were independently associated with unsuccessful outcomes.

Conclusion: ACF detected a significant proportion of TB cases in study townships; treatment outcomes in cases detected using ACF and those detected using PCF were similar. More tailored interventions are needed to improve treatment outcomes in patients at a higher risk of unsuccessful treatment outcomes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antitubercular Agents / therapeutic use
  • Case Management / organization & administration*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mass Screening / methods*
  • Mass Screening / organization & administration
  • Middle Aged
  • Myanmar / epidemiology
  • Retrospective Studies
  • Sputum / microbiology
  • Treatment Outcome
  • Tuberculosis / diagnosis*
  • Tuberculosis / epidemiology*
  • Tuberculosis / therapy
  • Young Adult

Substances

  • Antitubercular Agents